BioNTech
Vaccine maker BioNTech to build mRNA facilities in Rwanda and Senegal and other stories
Today we look at a deal between BioNTech and Rwanda to set up an mRNA plant, continued protests against the military coup in Sudan, and more
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
